ESA Council

Bu YeapProfessor Bu Beng Yeap (President)

Medical School, University of Western Australia, Perth, WA
Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, WA/p>

Bu Yeap is a Professor in the Medical School, University of Western Australia, and a consultant endocrinologist in the Department of Endocrinology and Diabetes at Fiona Stanley Hospital, Perth, Western Australia. He provides inpatient and outpatient care at Fiona Stanley Hospital for people with endocrine disorders and diabetes. He supervises endocrinology advanced trainees and junior medical staff, and research and PhD students. His research focusses on epidemiological and clinical studies of hormones and health outcomes in men, and the interaction between hormones, diabetes and cardiovascular risk. Particular interests are in testosterone and male ageing, the relationship between testosterone and cardiovascular risk in middle-aged and older men, the interaction between diabetes and cardiovascular risk, and biomarkers for cardiometabolic disease. Bu was first author on the Endocrine Society of Australia’s Position Statement on Management of Male Hypogonadism published in the Medical Journal of Australia in 2016. He was an investigator in the Testosterone for the Prevention of Type 2 Diabetes Mellitus (T4DM) study, an Australia-wide randomised controlled trial of testosterone to prevent or revert type 2 diabetes in men. He has ~250 publications, including ~200 original research articles (H-index 44, >6,700 citations, Web of Science, all databases; H-index 46, 9000 citations, Scopus).

 

Ann McCormackAssociate Professor Ann McCormack (President-elect) 

Department of Endocrinology | St Vincent’s Hospital | Sydney | NSW
Hormones and Cancer Group Leader | Garvan Institute of Medical Research | NSW
Conjoint Associate Professor | Faculty of Medicine | UNSW

A/Professor McCormack graduated in 2000 from the University of Sydney and undertook postgraduate training at the Royal North Shore Hospital. Her subsequent PhD examined the role of chemotherapy and genetic biomarkers in the management of aggressive pituitary tumours. In 2010 she completed a clinical and research fellowship in the Oxford Centre for Diabetes, Endocrinology and Metabolism, with a focus on pituitary tumours. She was then appointed to her current position as senior staff specialist in the Department of Endocrinology at St Vincent’s Hospital in 2011. She now also heads The Hormones and Cancer Group at the Garvan Institute of Medical Research. Her primary research interests are in exploring the biology of aggressive pituitary tumours and investigating new treatment options. She also has research interests in pituitary tumour genetics, particularly familial pituitary tumour syndromes. As a member for the European Society of Endocrinology’s Taskforce on Aggressive Pituitary Tumours, she was integral to the development of guidelines on the management of aggressive pituitary tumours published in 2017. She is board member of the International Pituitary Society, and holds other leadership positions within the pituitary field including chair of the St Vincent’s Campus pituitary multidisciplinary team, chair of the Sydney Pituitary Collaborative Group (SPCG) and co-chair of the Australia New Zealand Pituitary Alliance (ANZPA). 

 

Belinda HenryDr Belinda A. Henry (Treasurer)

Department of Physiology | Monash University | VIC

Belinda was awarded a BSc (Hons) degree in 1998 and her PhD in 2001 through Monash University. After her PhD, Belinda was awarded a CJ Martin Fellowship (NHMRC) to continue her research. During this fellowship period she worked at University of Bristol at the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology. Dr Henry currently holds an academic position in the Department of Physiology, Monash University. She is the program organising chair for the ESA Seminar weekend- basic science stream and is a member of both the US Endocrine Society and the Australasian Neuroendocrine Group. Dr Henry leads the Metabolic Neuroendocrinology group at Monash University. Her research centres on the discovery of novel means of altering energy expenditure through modulation of the brain. Her work is particularly focused on the process of thermogenesis and the mechanisms that underpin this process in fat and muscle tissues.

 

Professor Mathis Grossmann (Honorary Secretary)Mathis Grossman

University of Melbourne | VIC
Austin Health | VIC

Associate Professor Mathis Grossmann is a Principal Research Fellow at the Department of Medicine, University of Melbourne, Austin Health. He is a Consultant Endocrinologist and Head of Andrology at Austin Health, where he runs Endocrine Men’s Health and Endocrine Breast Cancer Clinics. He graduated with an MD from Heidelberg University Medical School and did his internship in Munich, Germany. He then spent 4 years in basic research at the National Institutes of Health, USA, and obtained a PhD at the Walter and Eliza Hall Institute in Melbourne, followed by clinical training leading to FRACP. He joined the University of Melbourne at Austin Health in 2006. His research focuses on the roles of reproductive hormones in health and disease. His group conducts observational and interventional trials in men with i) low testosterone and chronic disease, ii) hypogonadism, iii) prostate cancer receiving androgen deprivation therapy, and iv) women with breast cancer receiving aromatase inhibition to understand how reproductive hormones regulate musculoskeletal health and glucose homeostasis, both at the clinical and the molecular level.

 

Associate Professor (Peter) Shane HamblinShane Hamblin

Department of Endocrinology & Diabetes | Western Health | Sunshine Hospital | VIC 

Shane Hamblin is Head of Endocrinology & Diabetes at Western Health, Melbourne and a consultant endocrinologist at The Alfred, Melbourne. After graduating from Monash University, he trained in endocrinology & diabetes at The Alfred followed by two years at the University of Minnesota, Minneapolis USA, studying thyroid hormone action. He then worked for many years in private practice in Melbourne in addition to his public hospital appointments. He is an honorary Clinical Associate Professor (Principal Fellow) in the Department of Medicine- Western Precinct, Melbourne Medical School, The University of Melbourne and an Adjunct Senior Lecturer, Central Clinical School, Department of Medicine, Monash University. He is a member of the Pharmaceutical Benefits Advisory Committee. His main research interest is in clinical diabetes.

 

Diana Learoyd

Associate Professor Diana Learoyd

Genesis Care | St Leonards | NSW 

Diana is an Endocrinologist in private practice and an affiliate of the Northern Clinical School of the Faculty of Medicine and Health, University of Sydney. She trained at Royal North Shore Hospital and spent time at King’s College Hospital London, researching thyroid autoimmunity. She completed her PhD in the Kolling Institute of the University of Sydney in 1999, in the genetics of thyroid cancer and of MEN2. She became a full-time clinical academic consultant at RNSH in 1998 and has had many roles including the Director of Clinical Training and Co-Director of Physician Training. Her university roles have included Postgraduate Co-ordinator, Stage 3 lead, long case lead and MD project Co-ordinator for the Northern Clinical School. Diana expanded the thyroid cancer database at RNSH with a NSW Cancer Institute grant, and had a major role in the initial TKI clinical trials run at RNSH. She participates actively in the endocrine tumour MDT and has a busy clinical practice in general endocrinology with a special interest in thyroid disease of all types. Diana is the Co-Convenor of the ESA Seminar 2020-2022.

 

Emily MacKenzieDr Emily Mackenzie

Department of Diabetes and Endocrinology | Princess Alexandra Hospital | Woolloongabba | QLD

Emily Mackenzie graduated from the University of Qld (UQ) and undertook her Fellowship training in Brisbane, completing training in both Endocrinology and Nuclear Medicine.  She is a Staff Specialist in both these specialties at Princess Alexandra Hospital and is a Senior Lecturer with UQ. Her clinical interests include endocrine neoplasia – one of the intersections of Endocrinology and Nuclear Medicine. In addition to her clinical practice, she has an interest in junior staff education. She has organised the meetings of the South East Qld Endocrine Group for more than a decade. Her involvement in the ESA has been as the Local Convenor of the Clinical Weekend 2012 and as a member of the organising committee of the Seminar Weekend 2014-16.


Fran MilatAssociate Professor Frances Milat

Deputy Director of Endocrinology | Monash Health | VIC
Metabolic Bone Services | Monash Health | VIC
Metabolic Bone Research Group | Hudson Institute of Medical Research | VIC
School of Clinical Sciences | Monash University | VIC

Frances is a Consultant Endocrinologist, Deputy Director of Endocrinology and Head of the Metabolic Bone Services at Monash Health, Head of the Metabolic Bone Research Group at the Hudson Institute and Adjunct Associate Professor in the School of Clinical Sciences, Monash University. Associate Professor Frances Milat is committed to improving patient care through clinical research, with interests in osteoporosis and metabolic bone disorders associated with chronic medical conditions including neurological disability, kidney disease, haematological disorders, early menopause and breast cancer. She is involved in the supervision of research students as well as medical student and postgraduate teaching.

 

Ada CheungDr Ada Cheung

Endocrinologist | NHMRC Research Fellow
Department of Medicine (Austin Health) | The University of Melbourne | VIC

Ada Cheung is an endocrinologist at Austin Health, Victoria and in private practice. She is currently an NHMRC and Dame Kate Campbell research fellow at The University of Melbourne. Following the completion of her PhD in andrology, over the last 4 years, Ada has established a Trans Health Research group. She has won a number of national and international awards for her research and community leadership including a US Endocrine Society Early Investigator Award and an Inspirational Woman Award for International Women’s Day 2020 at Austin Health. She led new national guidelines on the hormonal management of transgender individuals published in the Medical Journal of Australia in 2019. She is a Fellow of the Institute of Community Directors Australia attaining a Diploma of Business (Governance) in order to most effectively serve on boards. She serves on various professional organization committees and is an editorial board member for Journal of Clinical Endocrinology and Metabolism and Therapeutic Advances in Endocrinology and Metabolism.

 

Professor Timothy J. Cole (Past- President)Tim Cole

Department of Biochemistry & Molecular Biology | Monash University | VIC

Professor Cole has a tenured academic position at the Department of Biochemistry & Molecular Biology, Monash University in Melbourne, he is currently the Deputy Head of Department and he leads a medical research group investigating cell signaling steroid endocrine pathways important for mammalian respiratory development and function. He is currently on the Council of the Endocrine Society of Australia as the Honorary Secretary, a member of the US Endocrine Society and is on the editorial board of the journal Endocrinology. Professor Cole’s main research interests are the developmental roles of the adrenal steroid hormones that act through nuclear receptors, particularly related to respiratory development and premature babies. Other interests include the use of synthetic steroids to treat a range of inflammatory, respiratory and metabolic diseases. His laboratory has published extensively on the role of these steroid signaling pathways in various systems in the body.

 

Secretariat

Mrs Ivone Johnson
See: Contact ESA page for details and contact form.